Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies are also included for percutaneous  treatment areas, such as stroke, venous vascular, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin...

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital. 

Feature | Heart Valve Technology | May 14, 2018

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-...

The Medtronic Endeavor drug-eluting stent was used in the PERSPECTIVE trial to test its durability in chronic total occlusions (CTOs). #SCAI, #SCAI2018

The Medtronic Endeavor drug-eluting stent was used in the PERSPECTIVE trial to test its durability in chronic total occlusions (CTOs).

News | Chronic Total Occlusion (CTO) | May 14, 2018

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary...

The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.  #SCAI, #SCAI2018

The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.

News | Heart Valve Technology | May 14, 2018

May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict...

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the...

PROGRESS-CTO flow chart for the hybrid algorithm. #SCAI, #SCAI2018
News | Chronic Total Occlusion (CTO) | May 14, 2018

May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total...

Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018

Richard Schatz, M.D., (center) research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a 2018 SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program, Sidra Medical and Research Center, Doha, Qatar, who has been active in new device technologies for structural heart disease.

Feature | SCAI | May 14, 2018

Here is an aggregation of all the news and late-breaking studies presented at the 2018...

News | Heart Failure | May 14, 2018

May 14, 2018 — Ancora Heart Inc. announced the expansion of the company’s U.S....

First-Ever Risk Tool Helps Predict TAVR Readmission Rates in 2018 SCAI late-breaking study. #SCAI, #SCAI2018
News | Heart Valve Technology | May 11, 2018

May 11, 2018 — A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in...

Novel Way to Treat Blood Clots in Lungs, pulmonary embolism, Found Safe and Effective. #SCAI, #SCAI2018
News | Pulmonary Embolism | May 11, 2018

May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking...

More Patients Admitted With Cardiac Conditions such as heart attacks in Winter Than other Months
News | May 11, 2018

 

May 11, 2018 — Two studies examining seasonal variations in cardiac-related hospitalizations, specifically...

A MitraClip device being deployed to clasp together the leaflets of the mitral valve. This mimics a surgical suture repair to create a double orifice valve with better leaflet coaptation to prevent mitral regurgitation. Abbott Mitraclip device.

A MitraClip device being deployed to clasp together the leaflets of the mitral valve. This mimics a surgical suture repair to create a double orifice valve with better leaflet coaptation to prevent mitral regurgitation.

News | Structural Heart | May 11, 2018

May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial...

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018

May 10, 2018 — Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several...

A patient injuried by extreme exposure to X-ray radiation during an angiography procedure, which is included among the images in the American College of Cardiology (ACC) consensus document. Angiography skin burn.

A patient injured by extreme exposure to X-ray radiation during an angiography procedure, which is included among the images in the consensus document. Severe skin injury typically appears four to eight weeks following the exposure. In extreme cases, the ulceration can become confluent and full thickness necrosis of skin may develop, exposing underlying fat, muscle and even bone.

 

News | Radiation Dose Management | May 10, 2018

May 10, 2018 — A new consensus document has been issued to guide the optimal use of ionizing radiation in...

The ZerGravity radiation protection system. The Zero Gravity suit allows interventional radiologists and cardiologists to shed their lead aprons in the cath lab.

One radiation protection technology that often has operators packed around displays at some conference expos waiting to try it out is the ZeroGravity system. It is a ceiling suspended suit that offers more protection than standard aprons, including full body protection including the face. It allows operators to shed their lead aprons and eliminate any weight on the operator’s back, helping alleviate orthopedic back pain. 

Blog | Radiation Dose Management | May 10, 2018

In the past, there was not much that could be done to mitigate the X-ray...

Overlay Init